Abbonarsi

Stroke rehabilitation pathways during the first year: A cost-effectiveness analysis from a cohort of 460 individuals - 09/05/24

Doi : 10.1016/j.rehab.2024.101824 
Pedro Maciel Barbosa a, b, c, , Helena Szrek d, Lara Noronha Ferreira e, f, g , Vitor Tedim Cruz b, h, João Firmino-Machado h, i, j
a Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal 
b Hospital Pedro Hispano, Unidade Local de Saúde, EPE, Rua de Alfredo Cunha 365, 4450-021 Matosinhos, Portugal 
c Centro de Investigação em Reabilitação, Escola Superior de Saúde, Instituto Politécnico do Porto, R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal 
d Centre for Economics and Finance, University of Porto, R. Dr. Roberto Frias, 4200-464 Porto, Portugal 
e ESGHT, Universidade do Algarve, Estr. da Penha 139, 8005-246 Faro, Portugal 
f Centre for Health Studies and Research of the University of Coimbra, Avenida Dias da Silva 165, 3004-512 Coimbra, Portugal 
g Research Centre for Tourism, Sustainability and Well-Being (CinTurs), Portugal 
h EPIUnit, Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal 
i Centro Académico Clínico Egas Moniz, 810-193 Aveiro, Portugal 
j Centro Hospitalar Vila Nova de Gaia/Espinho, R. Conceição Fernandes S/N, 4434-502 Vila Nova de Gaia, Portugal 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

First cost-effectiveness analysis of different stroke rehabilitation pathways.
Inpatient unit followed by a community clinic was the most cost-effective pathway.
Day hospital followed by a community clinic was also a cost-effective pathway.
Cost-effectiveness analysis is consistent with stroke evidence-based practice.
The incremental cost-effectiveness ratios are coherent between both perspectives.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background

Stroke burden challenges global health, and social and economic policies. Although stroke recovery encompasses a wide range of care, including in-hospital, outpatient, and community-based rehabilitation, there are no published cost-effectiveness studies of integrated post-stroke pathways.

Objective

To determine the most cost-effective rehabilitation pathway during the first 12 months after a first-ever stroke.

Methods

A cohort of people in the acute phase of a first stroke was followed after hospital discharge; 51 % women, mean (SD) age 74.4 (12.9) years, mean National Institute of Health Stroke Scale score 11.7 (8.5) points, and mode modified Rankin Scale score 3 points. We developed a decision tree model of 9 sequences of rehabilitation care organised in 3 stages (3, 6 and 12 months) through a combination of public, semi-public and private entities, considering both the individual and healthcare service perspectives. Health outcomes were expressed as quality-adjusted life years (QALY) over a 1-year time horizon. Costs included healthcare, social care, and productivity losses. Sensitivity analyses were conducted on model input values.

Results

From the individual perspective, pathway 3 (Short-term Inpatient Unit » Community Clinic) was the most cost-effective, followed by pathway 1 (Rehabilitation Centre » Community Clinic). From the healthcare service perspective, pathway 3 was the most cost-effective followed by pathway 7 (Outpatient Hospital » Private Clinic). All other pathways were considered strongly dominated and excluded from the analysis. The total 1-year mean cost ranged between €12104 and €23024 from the individual's perspective and between €10992 and €31319 from the healthcare service perspective.

Conclusion

Assuming a willingness-to-pay threshold of one times the national gross domestic product (€20633/QALY), pathway 3 (Short-term Inpatient Unit » Community Clinic) was the most cost-effective strategy from both the individual and healthcare service perspectives. Rehabilitation pathway data contribute to the development of a future integrated care system adapted to different stroke profiles.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Pathway, Stroke, Rehabilitation, Outcomes, Cost-analysis, Health policy

Abbreviations : C, H, HB, ICER, MMSE, mRS, N, NHS, NIHSS, P, QALY, RC, UL, UM, US, WHO, WTP


Mappa


© 2024  The Author(s). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 67 - N° 4

Articolo 101824- maggio 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Non-pharmacological and pharmacological treatments for bone health after stroke: Systematic review with meta-analysis
  • Huixi Ouyang, Tsun C. Lee, Faye YF Chan, Xun Li, King Y. Lai, Wing Y. Lam, Tsz Y. Yung, Marco Y.C. Pang
| Articolo seguente Articolo seguente
  • Twelve-month recovery following road trauma: Results from an inception cohort in Vancouver, Canada
  • Lulu X Pei, Herbert Chan, John A Staples, John A Taylor, Devin R Harris, Lina Jae, Jeffrey R Brubacher

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.